Krsnaa Diagnostics Limited (KRSNAA.NS)
INR 910.0
(-0.9%)
INR 910.0
(-0.9%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 55 Million INR | -77.35% |
| 2022 | 242.84 Million INR | -26.58% |
| 2021 | 330.74 Million INR | -80.31% |
| 2020 | 1.67 Billion INR | 36.87% |
| 2019 | 1.22 Billion INR | 33.31% |
| 2018 | 920.53 Million INR | -48.3% |
| 2017 | 1.78 Billion INR | 771.38% |
| 2016 | 204.34 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 27.5 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 379.64 Million INR | 0.0% |
| 2023 FY | 55 Million INR | -77.35% |
| 2023 Q4 | 55 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 242.84 Million INR | -26.58% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 242.84 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 300.21 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 330.74 Million INR | -80.31% |
| 2021 Q4 | 330.74 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 362.03 Million INR | 0.0% |
| 2020 Q4 | 1.51 Billion INR | 0.0% |
| 2020 FY | 1.67 Billion INR | 36.87% |
| 2019 Q4 | 6.17 Billion INR | 0.0% |
| 2019 FY | 1.22 Billion INR | 33.31% |
| 2018 FY | 920.53 Million INR | -48.3% |
| 2017 FY | 1.78 Billion INR | 771.38% |
| 2016 FY | 204.34 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Dr. Lal PathLabs Limited | 1.03 Billion INR | 94.66% |
| Metropolis Healthcare Limited | 1.19 Billion INR | 95.381% |
| Thyrocare Technologies Limited | 109.1 Million INR | 49.588% |
| Vijaya Diagnostic Centre Limited | 2.39 Billion INR | 97.699% |
| Vimta Labs Limited | 90.74 Million INR | 39.387% |